EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention

Samuel T Wilkinson, Brandon M Kitay, Matthew Macaluso, Mia C Santucci, Kristina Kumpf, Cindy Voghell, Lauren Astorino, Rachel Hershenberg, Valeria Martinez-Kaigi, Tiffany Nowell, Michael E Thase, Gerard Sanacora und 1 weitere

The Journal of Clinical Psychiatry · 04.05.2026 · 87 (2)

DOI: 10.4088/jcp.25m16285 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Psychiatry, online erschienen am 04.05.2026. Verfasst von Samuel T Wilkinson und 12 weiteren Autor:innen. Beteiligte Einrichtung: Yale Depression Research Program, Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut. Hauptthemen laut MEDLINE: Cognitive Behavioral Therapy, Major Depressive Disorder, Suicidal Ideation, Secondary Prevention. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Gefördert von: NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive Behavioral TherapyMajor Depressive DisorderSuicidal IdeationSecondary PreventionAntidepressive AgentsHumansFemaleAdultCombined Modality TherapyMaleMiddle AgedFeasibility StudiesTreatment OutcomeKetamine

Substanzen

EsketamineAntidepressive AgentsKetamine

Autor:innen und Institutionen

  • Yale Depression Research Program, Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.
  • Department of Psychiatry, Emory University School of Medicine, Atlanta, Georgia.
  • Department of Psychiatry, University of Alabama at Birmingham, School of Medicine, Birmingham, Alabama.
  • Yale Center for Clinical Investigation, Yale School of Medicine, New Haven, Connecticut.
  • Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Förderung

  • NIMH NIH HHS

Zitieren

APA

Wilkinson, S. T., Kitay, B. M., Macaluso, M., Santucci, M. C., Kumpf, K., Voghell, C., Astorino, L., Hershenberg, R., Martinez-Kaigi, V., Nowell, T., Thase, M. E., Sanacora, G., & Rhee, T. G. (2026). Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention. The Journal of Clinical Psychiatry, 87(2). https://doi.org/10.4088/jcp.25m16285

Vancouver

Wilkinson ST, Kitay BM, Macaluso M, Santucci MC, Kumpf K, Voghell C, et al. Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention. The Journal of Clinical Psychiatry. 2026;87(2). doi:10.4088/jcp.25m16285

BibTeX
@article{Wilkinson2026,
  author = {Wilkinson, Samuel T and Kitay, Brandon M and Macaluso, Matthew and Santucci, Mia C and Kumpf, Kristina and Voghell, Cindy and Astorino, Lauren and Hershenberg, Rachel and Martinez-Kaigi, Valeria and Nowell, Tiffany and Thase, Michael E and Sanacora, Gerard and Rhee, T Greg},
  title = {Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention},
  journal = {The Journal of Clinical Psychiatry},
  year = {2026},
  volume = {87},
  number = {2},
  doi = {10.4088/jcp.25m16285}
}
Kostenlos starten →